Skip to content

Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial

Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01118715
Enrollment
128
Registered
2010-05-07
Start date
2010-04-30
Completion date
2017-09-30
Last updated
2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndrome, Edema, Post-traumatic Carpal Tunnel Syndrome

Keywords

distal radius fracture, post-traumatic carpal tunnel syndrome, complex regional pain syndrome, compression glove, edema glove

Brief summary

Distal radius fractures (DRF) are the most common type of fracture in the human body, and a large proportion of DRFs result in complications. Previously proposed preventive strategies have questionable efficacy and may impose additional risks on the patient. Because many complications secondary to distal radius fractures are associated with excessive swelling, a prophylactic means for edema reduction could dramatically reduce morbidity among this population. A compression glove is a non-invasive, non-pharmacological way to reduce edema. Previous studies have confirmed its utility in edema reduction after hand trauma and among patients with chronic inflammatory conditions, but none have sufficiently investigated the application to patients with distal radius fractures, a population in which this intervention could have a large impact. The investigators propose a randomized controlled trial to evaluate use of a compression glove during recovery among patients who have sustained an unstable distal radius fracture. The investigators hypothesize that patients who wear a compression glove after a distal radius fracture: * Will experience less edema * Will demonstrate greater functionality * Will recover more quickly * Will have lower incidence rates of carpal tunnel syndrome * Will have lower incidence rates of complex regional pain syndrome

Detailed description

Patients will be recruited from the principle investigator's practice at Athens Orthopedic Clinic. As the only hand and upper-extremity surgeon in the Athens-Clarke county metro area, principle investigator performs the majority of this type of surgery for patients in Athens and surrounding cities. Therefore, the study population should be largely representative of the target population. Procedures: 1. Patient Identification: Patient presents with distal radius fracture. 1. An x-ray is taken to decide whether the fracture requires surgical stabilization. 2. Unstable distal radius fractures will be based on the following criteria: 1\. Radial shortening \<5 mm at the DRUJ compared with the contralateral side 2. Radial inclination on the posteroanterior radiographs \> 15⁰ 3. Sagittal tilt on the lateral projection between 15⁰ dorsal tilt and 20⁰ volar tilt 4. Intra-articular step-off or gap \<2 mm of the radiocarpal joint 5. Articular incongruity \<2 mm of the sigmoid notch of the distal radius 2. Screening: Patients whose fracture is unstable will be assessed for eligibility using the aforementioned criteria. 3\. Consent and de-identification: Patients who are deemed evaluable based on the eligibility criteria will be asked if they are interested in participating in a research study. 1. Those who are interested will meet with a member of the study team, who will explain the study and answer any questions the patient might have. 2. The participant will be given two (2) copies of the informed consent form and HIPAA authorization form. One copy of each document will be signed and returned to the study team, to be kept in a secure location, and the other copy will be given to the participant for his/her records. 3. Each study participant will be assigned a unique study identification number in order to keep his/her identity anonymous. The participant's name and study ID will be recorded on the first page of the case report form, which is detached and kept in a locked filing cabinet immediately following consent. All subsequent data collection will be recorded on the data collection form at follow-up visits with the principle investigator. Data will be entered into a secure, de-identified database by a member of the study team, using the patient's study ID as an identifier. The database will not contain any information that may be used to identify the patient. 4. Surgery: All fractures will be stabilized by volar plate fixation or closed reduction percutaneous pinning using a distal volar radial locking plate or other appropriate implant. 5. Randomization: To avoid any potential bias on the part of the surgeon, patients will be randomized postoperatively to receive either the investigational (glove) or control (no glove) intervention. Therefore, the surgeon will be blinded to intervention status until after patient enrollment and surgical stabilization. 6. Post-surgery: The wound will be dressed steriley, per standard protocol. Initial sterile cast padding will be placed over sterile dressing. For patients in the investigational group, the compression glove will be applied over cast padding, followed by additional padding and then a splint. Patients in the control group will be dressed identically, with the exception of glove application. The splint will be applied for two weeks post-surgery and removal of the splint and application of a short-arm cast will occur at five weeks post-surgery. Additional post-surgical procedures are as follows: a. 2 weeks- splint is removed; glove is taken off for edema measurements (investigational group); short- arm cast is applied b. 5 weeks- short-arm cast is removed; patient can continue to wear compression glove on an as-needed basis; patient is given post-operative exercise handout c. 3 months- patients meet with study physician for routine follow-up visit d. 6 months- patients meet with study physician for final follow-up visit; once fully healed, patient is given option of having plates removed 7. Therapy: Patients will be given a handout explaining post-operative exercises to be performed at home during recovery. 1. In addition, participants will attend therapy twice weekly, beginning five weeks from surgery. Duration of therapy will be as-needed at the therapist's discretion. Discharge from therapy will be based on the therapist's assessment that the patient has recovered to the extent that they can continue an exercise program at home. 2. Patients who stop coming to therapy prior to discharge will be contacted by the therapists and asked to provide his/her primary reason for not returning. 8. Outcome assessment: outcomes will be assessed at each of four follow-up visits, occurring two weeks, six weeks, three months, and six months from surgery. These coincide with regular post-operative visits, so as to minimize loss to follow-up. Each visit will assess each of the outcome measurements explained in later sections.

Interventions

DEVICECompression glove

A compression glove worn during recovery from distal radius fracture

Sponsors

J&M Shuler
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Male or female * Between the ages of 18-85 * Patients with unstable unilateral distal radius fractures (requiring surgical stabilization)

Exclusion criteria

* Pre-existing cases of carpal tunnel syndrome and/or complex regional pain syndrome * Nerve or tendon laceration * Decompression of carpal tunnel concomitant with surgical stabilization * Additional fractures, including carpal fractures, more proximal fractures of the radius, and finger injuries will be excluded from the study (Ulnar styloid and ulnar head and neck fractures will be included) * Uncontrolled rheumatoid arthritis patients * Bilateral fractures * Unable or unwilling to provide written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)2 wks-24 wksConfirmed cases of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)

Secondary

MeasureTime frameDescription
Grip Strength5 wks-24 wksGrip strength measured using a hand dynamometer at each visit except @ 2-weeks; grip strength was not measured at 2-weeks because of post-op activity restrictions recommended by the treating physician
Edema2 wks- 24 weeksCircumference of Wrist/Finger by Glove or No Glove
Range of Motion2 wks-24 wksCount of participants (by group) that were capable or full extension or flexion at each encounter.
DASH Score2 wks- 24 wksDisabilities of the Arm, Shoulder and Hand questionnaire (DASH) is 30-item questionnaire designed to quanitfy functional outcomes of the upper extremity and measure symptoms of pain, physical, emotional, and social domains associated with musculoskeletal disorders of the upper limb. Scores can range from 0-100 with 0 indicating NO disability and 100 indicating extreme disability.
Pain on Numerical Rating Scale2 wks- 24 wksAssessment of pain using a numerical rating scale of 0-10, where 0=no pain and 10=worst possible pain

Countries

United States

Participant flow

Pre-assignment details

The initial protocol had 94 participants. Analysis was run, however, numbers were trending but not significant. Additional participants were then enrolled to increase the power of the study, leading to a larger participant number(128) than the study originally intended to have. There is no intention to continue enrolling subjects.

Participants by arm

ArmCount
Compression Glove
Patients in this group have a compression glove incorporated into their splint for 2 weeks post-op, and wear a glove underneath their cast for 3 weeks. The patient then wears the glove at night after cast removal. Compression glove: A compression glove worn during recovery from distal radius fracture
68
Control
Patients in this group undergo standard recovery procedures. This includes a splint worn for 2 weeks post-op, followed by a short arm cast worn for the next 3 weeks.
60
Total128

Baseline characteristics

CharacteristicControlTotalCompression Glove
Age, Continuous59.6 years
STANDARD_DEVIATION 15.3
58.22 years
STANDARD_DEVIATION 18
57 years
STANDARD_DEVIATION 19.9
Injured wrist
Left
28 Participants66 Participants38 Participants
Injured wrist
Right
32 Participants62 Participants30 Participants
Pain Scale6.21 units on a scale
STANDARD_DEVIATION 12.7
5.17 units on a scale
STANDARD_DEVIATION 2.95
5.1 units on a scale
STANDARD_DEVIATION 2.7
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
46 Participants103 Participants57 Participants
Sex: Female, Male
Male
14 Participants25 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 680 / 60
serious
Total, serious adverse events
0 / 680 / 60

Outcome results

Primary

Incidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)

Confirmed cases of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)

Time frame: 2 wks-24 wks

Population: 'Number Analyzed' is broken down by group (Glove/No Glove) and time frame (2-24 weeks). The overall number of participants analyzed is not consistent with numbers provided in the participant flow module (total participants=128) because not all participants attended all follow-up appointments.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
2 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Glovenew dx of CTS or CRPS0 Participants
2 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Gloveno new dx of CTS or CRPS58 Participants
2 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Glovenew dx of CTS or CRPS0 Participants
2 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Gloveno new dx of CTS or CRPS65 Participants
5 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Gloveno new dx of CTS or CRPS52 Participants
5 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Glovenew dx of CTS or CRPS1 Participants
5 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Gloveno new dx of CTS or CRPS59 Participants
5 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Glovenew dx of CTS or CRPS4 Participants
12 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Glovenew dx of CTS or CRPS2 Participants
12 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Gloveno new dx of CTS or CRPS44 Participants
12 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Gloveno new dx of CTS or CRPS50 Participants
12 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Glovenew dx of CTS or CRPS4 Participants
24 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Gloveno new dx of CTS or CRPS39 Participants
24 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Gloveno new dx of CTS or CRPS47 Participants
24 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)No Glovenew dx of CTS or CRPS0 Participants
24 WeeksIncidence of Post-traumatic Carpal Tunnel Syndrome (CTS) or Complex Regional Pain Syndrome (CRPS)Glovenew dx of CTS or CRPS0 Participants
Secondary

DASH Score

Disabilities of the Arm, Shoulder and Hand questionnaire (DASH) is 30-item questionnaire designed to quanitfy functional outcomes of the upper extremity and measure symptoms of pain, physical, emotional, and social domains associated with musculoskeletal disorders of the upper limb. Scores can range from 0-100 with 0 indicating NO disability and 100 indicating extreme disability.

Time frame: 2 wks- 24 wks

Population: The overall number of participants analyzed is not consistent with numbers provided in the participant flow module (total participants=128) because not all participants attended all follow-up appointments. In addition, QAQC uncovered several cases of appointment records with missing or invalid data.

ArmMeasureGroupValue (MEAN)Dispersion
2 WeeksDASH ScoreNo Glove58.12 score on a scaleStandard Deviation 22.11
2 WeeksDASH ScoreGlove62.14 score on a scaleStandard Deviation 19.75
5 WeeksDASH ScoreGlove44.98 score on a scaleStandard Deviation 22.3
5 WeeksDASH ScoreNo Glove39.52 score on a scaleStandard Deviation 21.18
12 WeeksDASH ScoreNo Glove20.51 score on a scaleStandard Deviation 17.24
12 WeeksDASH ScoreGlove16.42 score on a scaleStandard Deviation 16.54
24 WeeksDASH ScoreNo Glove11.50 score on a scaleStandard Deviation 14.28
24 WeeksDASH ScoreGlove10.32 score on a scaleStandard Deviation 14.53
Secondary

Edema

Circumference of Wrist/Finger by Glove or No Glove

Time frame: 2 wks- 24 weeks

Population: The overall number of participants analyzed is not consistent with numbers provided in the participant flow module (total participants=128) because not all participants attended all follow-up appointments. In addition, QAQC uncovered several cases of appointment records with missing or invalid data.

ArmMeasureGroupValue (MEAN)Dispersion
2 WeeksEdemaNo Glove - Wrist Circumference18.09 centimetersStandard Deviation 1.34
2 WeeksEdemaGlove - Wrist Circumference17.66 centimetersStandard Deviation 1.46
2 WeeksEdemaNo Glove 1st Finger6.94 centimetersStandard Deviation 0.61
2 WeeksEdemaGlove 1st Finger6.61 centimetersStandard Deviation 0.7
2 WeeksEdemaNo Glove 2nd Finger6.77 centimetersStandard Deviation 0.64
2 WeeksEdemaGlove 2nd Finger6.47 centimetersStandard Deviation 0.72
2 WeeksEdemaNo Glove 3rd Finger6.29 centimetersStandard Deviation 0.58
2 WeeksEdemaGlove 3rd Finger6.09 centimetersStandard Deviation 0.69
2 WeeksEdemaNo Glove 4th Finger5.71 centimetersStandard Deviation 0.51
2 WeeksEdemaGlove 4th Finger5.56 centimetersStandard Deviation 0.68
5 WeeksEdemaNo Glove 1st Finger6.84 centimetersStandard Deviation 0.59
5 WeeksEdemaNo Glove 4th Finger5.82 centimetersStandard Deviation 0.53
5 WeeksEdemaGlove 1st Finger6.38 centimetersStandard Deviation 0.66
5 WeeksEdemaNo Glove 2nd Finger6.67 centimetersStandard Deviation 0.61
5 WeeksEdemaGlove 2nd Finger6.20 centimetersStandard Deviation 0.7
5 WeeksEdemaNo Glove 3rd Finger6.31 centimetersStandard Deviation 0.62
5 WeeksEdemaGlove 4th Finger5.46 centimetersStandard Deviation 0.68
5 WeeksEdemaGlove 3rd Finger5.86 centimetersStandard Deviation 0.69
5 WeeksEdemaNo Glove - Wrist Circumference17.53 centimetersStandard Deviation 1.36
5 WeeksEdemaGlove - Wrist Circumference16.98 centimetersStandard Deviation 1.5
12 WeeksEdemaGlove 3rd Finger5.85 centimetersStandard Deviation 0.73
12 WeeksEdemaNo Glove 3rd Finger5.99 centimetersStandard Deviation 0.52
12 WeeksEdemaGlove 4th Finger5.50 centimetersStandard Deviation 0.68
12 WeeksEdemaNo Glove - Wrist Circumference16.98 centimetersStandard Deviation 1.37
12 WeeksEdemaGlove 1st Finger6.57 centimetersStandard Deviation 0.68
12 WeeksEdemaGlove 2nd Finger6.31 centimetersStandard Deviation 0.73
12 WeeksEdemaNo Glove 4th Finger5.58 centimetersStandard Deviation 0.5
12 WeeksEdemaGlove - Wrist Circumference16.75 centimetersStandard Deviation 1.6
12 WeeksEdemaNo Glove 2nd Finger6.37 centimetersStandard Deviation 0.56
12 WeeksEdemaNo Glove 1st Finger6.59 centimetersStandard Deviation 0.56
24 WeeksEdemaNo Glove 2nd Finger6.28 centimetersStandard Deviation 0.41
24 WeeksEdemaGlove 3rd Finger5.98 centimetersStandard Deviation 0.76
24 WeeksEdemaGlove 2nd Finger6.43 centimetersStandard Deviation 0.83
24 WeeksEdemaGlove 4th Finger5.56 centimetersStandard Deviation 0.71
24 WeeksEdemaNo Glove 3rd Finger5.84 centimetersStandard Deviation 0.41
24 WeeksEdemaGlove - Wrist Circumference17.01 centimetersStandard Deviation 1.56
24 WeeksEdemaNo Glove 1st Finger6.50 centimetersStandard Deviation 0.44
24 WeeksEdemaGlove 1st Finger6.62 centimetersStandard Deviation 0.79
24 WeeksEdemaNo Glove - Wrist Circumference16.74 centimetersStandard Deviation 1.24
24 WeeksEdemaNo Glove 4th Finger5.45 centimetersStandard Deviation 0.41
Secondary

Grip Strength

Grip strength measured using a hand dynamometer at each visit except @ 2-weeks; grip strength was not measured at 2-weeks because of post-op activity restrictions recommended by the treating physician

Time frame: 5 wks-24 wks

Population: The overall number of participants analyzed is not consistent with numbers provided in the participant flow module (total participants=128) because not all participants attended all follow-up appointments. In addition, QAQC uncovered several cases of appointment records with missing or invalid data.

ArmMeasureGroupValue (MEAN)Dispersion
2 WeeksGrip StrengthNo Glove6.83 kgStandard Deviation 6.14
2 WeeksGrip StrengthGlove7.39 kgStandard Deviation 6.04
5 WeeksGrip StrengthNo Glove17.79 kgStandard Deviation 9.17
5 WeeksGrip StrengthGlove18.10 kgStandard Deviation 10.44
12 WeeksGrip StrengthNo Glove20.73 kgStandard Deviation 11.69
12 WeeksGrip StrengthGlove23.45 kgStandard Deviation 10.28
Secondary

Pain on Numerical Rating Scale

Assessment of pain using a numerical rating scale of 0-10, where 0=no pain and 10=worst possible pain

Time frame: 2 wks- 24 wks

Population: The overall number of participants analyzed is not consistent with numbers provided in the participant flow module (total participants=128) because not all participants attended all follow-up appointments. In addition, QAQC uncovered several cases of appointment records with missing or invalid data.

ArmMeasureGroupValue (MEAN)Dispersion
2 WeeksPain on Numerical Rating ScaleNo Glove2.93 units on a scaleStandard Deviation 2.03
2 WeeksPain on Numerical Rating ScaleGlove3.24 units on a scaleStandard Deviation 2.31
5 WeeksPain on Numerical Rating ScaleGlove1.75 units on a scaleStandard Deviation 1.57
5 WeeksPain on Numerical Rating ScaleNo Glove2.42 units on a scaleStandard Deviation 2.11
12 WeeksPain on Numerical Rating ScaleGlove1.03 units on a scaleStandard Deviation 1.48
12 WeeksPain on Numerical Rating ScaleNo Glove1.32 units on a scaleStandard Deviation 1.61
24 WeeksPain on Numerical Rating ScaleNo Glove.81 units on a scaleStandard Deviation 1.06
24 WeeksPain on Numerical Rating ScaleGlove.73 units on a scaleStandard Deviation 1.08
Secondary

Range of Motion

Count of participants (by group) that were capable or full extension or flexion at each encounter.

Time frame: 2 wks-24 wks

Population: The overall number of participants analyzed is not consistent with numbers provided in the participant flow module (total participants=128) because not all participants attended all follow-up appointments. In addition, QAQC uncovered several cases of appointment records with missing or invalid data. Flexion data missing for 3 subjects and extension data missing for 1 subject at 2 wk visit.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
2 WeeksRange of MotionGlove - Full Extension44 Participants
2 WeeksRange of MotionGlove - Full Flexion20 Participants
2 WeeksRange of MotionNo Glove - Full Extension45 Participants
2 WeeksRange of MotionNo Glove - Full Flexion24 Participants
5 WeeksRange of MotionGlove - Full Flexion31 Participants
5 WeeksRange of MotionGlove - Full Extension47 Participants
5 WeeksRange of MotionNo Glove - Full Extension44 Participants
5 WeeksRange of MotionNo Glove - Full Flexion25 Participants
12 WeeksRange of MotionNo Glove - Full Extension33 Participants
12 WeeksRange of MotionGlove - Full Flexion34 Participants
12 WeeksRange of MotionNo Glove - Full Flexion32 Participants
12 WeeksRange of MotionGlove - Full Extension35 Participants
24 WeeksRange of MotionGlove - Full Extension26 Participants
24 WeeksRange of MotionGlove - Full Flexion26 Participants
24 WeeksRange of MotionNo Glove - Full Extension29 Participants
24 WeeksRange of MotionNo Glove - Full Flexion28 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026